Original Query: ALL
Previous Study | Return to List | Next Study

Erlotinib, Docetaxel, and Radiation Therapy in Stage III or Stage IV Squamous Cell Carcinoma of the Head and Neck

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00720304
Recruitment Status : Completed
First Posted : July 22, 2008
Last Update Posted : November 26, 2015
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Case Comprehensive Cancer Center

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : November 2015
  Study Completion Date : November 2015